Insights | Life sciences and healthcare | Hong Kong SAR | Global law firm | Norton Rose Fulbright Skip to main content
Norton Rose Fulbright logo
  • Hong Kong SAR
  • About
    • Our firm
      • Clients
      • Global coverage
      • Vision, culture and people
      • Governance structure
      • Risk management
      • NRF Transform
      • Alumni
    • Diversity, Equity & Inclusion
      • Strategy, goals and priorities
      • Governance and policy
      • Resource groups
    • Responsible business
      • EMEA Responsible business report
      • Pro bono
      • Volunteering
      • Fundraising
      • Sustainable practice
      • Global charitable initiatives
  • People
  • Services
    • Services A-Z
    • Key industries
      • Consumer markets
      • Energy, infrastructure and resources
      • Financial institutions
      • Life sciences and healthcare
      • Technology
      • Transport
    • Practices
      • Antitrust and competition
      • Climate change and sustainability
      • Cybersecurity and data privacy
      • Energy
      • Financial services and regulation
      • Litigation and disputes
      • Projects
      • Regulation and investigations
      • Risk advisory
      • Banking and finance
      • Corporate, M&A and securities
      • Employment and labor
      • Environmental, social and governance (ESG)
      • Intellectual property
      • Private equity and venture capital
      • Real estate
      • Restructuring
      • Tax
    • NRF Transform
    • Transform image

      Find out more
  • Insights
    • Publications
    • Podcasts
    • Blogs
    • Webinars and events
    • Videos
    • NRF Institute
    • Professional development
    • Resources and tools
    • Connections
    • Reflection of trees and mountains on a lake

      Insights, perspectives and viewpoints
      from our lawyers on topical issues

      Latest insights
  • News
    • Press releases
    • Market recognitions
    • Media information
  • Locations
    • Bangkok
    • Beijing
    • Hong Kong SAR
    • Jakarta
    • Shanghai
    • Singapore
    • Tokyo
    • Global coverage
  • Careers
    • Graduates and students
    • Legal
      • Search current vacancies
      • Change
      Norton Rose Fulbright logo

      1. Services
      2. Life sciences and healthcare

      Life sciences and healthcare

      Life sciences and healthcare
      Overview Insights People
      Subscribe to our insights
      • Life sciences and healthcare
      • Overview
      • Insights
      • People
      • Subscribe to our insights
    • Publication

      The GCR Guide to Life Sciences

      October 17, 2024

      Life sciences and healthcare
      Process of in vitro fertilization in laboratory

      Publication

      The GCR Guide to Life Sciences – Product denigration

      Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been ...

      October 17, 2024

      Antitrust and competition
      Blue double-helix placed to the right with a digital blue backdrop

      Publication

      The GCR Guide to Life Sciences – Merger control: Procedural issues

      Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural...

      October 17, 2024

      Life sciences and healthcare
      AI

      Publication

      Artificial intelligence and liability: Key takeaways from recent EU legislative initiatives

      The EU’s Artificial Intelligence Regulation, commonly referred to as the AI Act, is expected to come into force during t...

      July 10, 2024

      Artificial intelligence (AI)
      european-union-flag

      Publication

      The European Commission’s prohibition of Illumina's acquisition of GRAIL

      On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the adm...

      April 17, 2024

      Life sciences and healthcare
      life-sciences-and-healthcare-drugs-medicine

      Publication

      The GCR Guide to Life Sciences

      October 17, 2024

      Life sciences and healthcare
      Process of in vitro fertilization in laboratory

      Publication

      The GCR Guide to Life Sciences – Product denigration

      Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been ...

      October 17, 2024

      Antitrust and competition
      Blue double-helix placed to the right with a digital blue backdrop

      Publication

      The GCR Guide to Life Sciences – Merger control: Procedural issues

      Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural...

      October 17, 2024

      Life sciences and healthcare
      AI

      Publication

      Artificial intelligence and liability: Key takeaways from recent EU legislative initiatives

      The EU’s Artificial Intelligence Regulation, commonly referred to as the AI Act, is expected to come into force during t...

      July 10, 2024

      Artificial intelligence (AI)
      european-union-flag

      Publication

      The European Commission’s prohibition of Illumina's acquisition of GRAIL

      On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the adm...

      April 17, 2024

      Life sciences and healthcare
      More

      Events and webinars

      People pushing colored shapes

      On demand

      Healthcare industry focus on FTC’s near-total ban on non-competes

      Watch now
      Subscribe to insights

      Subscribe to our insights

      Stay up to date with the latest publications, podcasts, webinars and events
      Subscribe

      © Norton Rose Fulbright LLP 2025

      Explore our site

      • About
      • Careers
      • Diversity, Equity & Inclusion
      • People
      • Services
      • Insights
      • News

      Key industries

      • Consumer markets
      • Energy, infrastructure and resources
      • Financial institutions
      • Life sciences and healthcare
      • Technology
      • Transport

      Locations

      • Global coverage

      Norton Rose Fulbright © 2025. All Rights Reserved.

      • Amsterdam
      • ●
      • Athens
      • ●
      • Austin
      • ●
      • Bangkok
      • ●
      • Beijing
      • ●
      • Brisbane
      • ●
      • Brussels
      • ●
      • Bujumbura**
      • ●
      • Calgary
      • ●
      • Canberra
      • ●
      • Cape Town
      • ●
      • Casablanca
      • ●
      • Chicago
      • ●
      • Dallas
      • ●
      • Denver
      • ●
      • Dubai
      • ●
      • Durban
      • ●
      • Düsseldorf
      • ●
      • Frankfurt
      • ●
      • Hamburg
      • ●
      • Harare**
      • ●
      • Hong Kong SAR
      • ●
      • Houston
      • ●
      • Istanbul
      • ●
      • Jakarta*
      • ●
      • Johannesburg
      • ●
      • Kampala**
      • ●
      • London
      • ●
      • Los Angeles
      • ●
      • Luxembourg
      • ●
      • Melbourne
      • ●
      • Mexico City
      • ●
      • Milan
      • ●
      • Minneapolis
      • ●
      • Montréal
      • ●
      • Munich
      • ●
      • Nairobi**
      • ●
      • Newcastle
      • ●
      • New York
      • ●
      • Ottawa
      • ●
      • Paris
      • ●
      • Perth
      • ●
      • Piraeus
      • ●
      • Québec
      • ●
      • Riyadh*
      • ●
      • San Antonio
      • ●
      • San Francisco
      • ●
      • São Paulo
      • ●
      • Shanghai
      • ●
      • Singapore
      • ●
      • St. Louis
      • ●
      • Sydney
      • ●
      • Tokyo
      • ●
      • Toronto
      • ●
      • Vancouver
      • ●
      • Warsaw
      • ●
      • Washington DC *associate office **alliance
      • Legal notices and disclaimers
      • Impressum
      • Standard terms
      • Blog network terms and conditions
      • Cookies policy
      • Privacy notice
      • Website access conditions
      • Fraud alerts
      • Modern Slavery Statements
      • Health plan machine readable files
      • Anti-Facilitation of Tax Evasion Statement
      • Suppliers
      • History
      • Remote access
      • Sitemap
      Offices and locations

      Norton Rose Fulbright © 2025. All Rights Reserved.

      • Amsterdam
      • ●
      • Athens
      • ●
      • Austin
      • ●
      • Bangkok
      • ●
      • Beijing
      • ●
      • Brisbane
      • ●
      • Brussels
      • ●
      • Bujumbura**
      • ●
      • Calgary
      • ●
      • Canberra
      • ●
      • Cape Town
      • ●
      • Casablanca
      • ●
      • Chicago
      • ●
      • Dallas
      • ●
      • Denver
      • ●
      • Dubai
      • ●
      • Durban
      • ●
      • Düsseldorf
      • ●
      • Frankfurt
      • ●
      • Hamburg
      • ●
      • Harare**
      • ●
      • Hong Kong SAR
      • ●
      • Houston
      • ●
      • Istanbul
      • ●
      • Jakarta*
      • ●
      • Johannesburg
      • ●
      • Kampala**
      • ●
      • London
      • ●
      • Los Angeles
      • ●
      • Luxembourg
      • ●
      • Melbourne
      • ●
      • Mexico City
      • ●
      • Milan
      • ●
      • Minneapolis
      • ●
      • Montréal
      • ●
      • Munich
      • ●
      • Nairobi**
      • ●
      • Newcastle
      • ●
      • New York
      • ●
      • Ottawa
      • ●
      • Paris
      • ●
      • Perth
      • ●
      • Piraeus
      • ●
      • Québec
      • ●
      • Riyadh*
      • ●
      • San Antonio
      • ●
      • San Francisco
      • ●
      • São Paulo
      • ●
      • Shanghai
      • ●
      • Singapore
      • ●
      • St. Louis
      • ●
      • Sydney
      • ●
      • Tokyo
      • ●
      • Toronto
      • ●
      • Vancouver
      • ●
      • Warsaw
      • ●
      • Washington DC *associate office **alliance
      Policies and disclaimers
      • Legal notices and disclaimers
      • Impressum
      • Standard terms
      • Blog network terms and conditions
      • Cookies policy
      • Privacy notice
      • Website access conditions
      • Fraud alerts
      • Modern Slavery Statements
      • Health plan machine readable files
      • Anti-Facilitation of Tax Evasion Statement
      • Suppliers
      • History
      • Remote access
      • Sitemap
      Visit our global site, or select a location
      North America
      • Canada (English)
      • Canada (Français)
      • United States
      Latin America
      • Brazil
      • Mexico
      Europe
      • Belgium
      • Deutschland (Deutsch)
      • France
      • Germany (English)
      • Greece
      • Italy
      • Luxembourg
      • Poland
      • The Netherlands
      • Türkiye
      • United Kingdom
      Middle East
      Africa
      • Burundi
      • Kenya
      • Morocco
      • South Africa
      • Uganda
      • Zimbabwe
      Asia Pacific
      • Australia
      • China
      • Hong Kong SAR
      • Indonesia
      • Japan
      • Singapore
      • Thailand
      Regional practices
      • India
      • Israel
      • Korea
      • Marshall Islands
      • Nordic region
      • Pakistan
      • Vietnam